Bufei huoxue capsules in the management of convalescent COVID‐19 infection: study protocol for a multicenter, double‐blind, and randomized controlled trial

Bufei huoxue capsules in the management of convalescent COVID‐19 infection: study protocol for a multicenter, double‐blind, and randomized controlled trial

Up to 30 May 2021, the cumulative number of patients diagnosed with corona virus disease‐19 (COVID‐19) globally has exceeded 170 million, with more than 152 million patients recovered from COVID‐19. However, the long‐term effect of the virus infection on the human body’s function is unknown for conv...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuqin Chen, Wenjun He, Wenju Lu, Yue Xing, Jianling Bai, Hao Yu, Jiawei Zhou, Jingyi Liang, Jiyuan Chen, Chi Hou, Bihua Zhong, Ting Wang, Huazhuo Feng, Xu Chen, Tao Wang, Kai Yang, Nuofu Zhang, Nanshan Zhong, Chunli Liu, Jian Wang
Format: Article
Language:English
Published: Wiley 2021-07-01
Series:Pulmonary Circulation
Subjects:
Bufei Huoxue capsules
novel coronavirus 2019
recovery period
randomized controlled trial
Online Access:https://doi.org/10.1177/20458940211032125
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items